☰

Awet G. Tecleab, Ph.D. - Publications

Affiliations: 
2013 Medical Sciences University of South Florida, Tampa, FL, United States 
Area:
Medicine and Surgery, Cell Biology, Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Tecleab A, Zhang X, Sebti SM. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation. The Journal of Biological Chemistry. 289: 31296-309. PMID 25210032 DOI: 10.1074/Jbc.M114.565796  0.59
2014 Kazi A, Ozcan S, Tecleab A, Sun Y, Lawrence HR, Sebti SM. Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity Journal of Biological Chemistry. 289: 11906-11915. PMID 24570003 DOI: 10.1074/Jbc.M113.533950  0.402
2013 Tecleab A, Sebti SM. Depletion of K-Ras promotes proteasome degradation of survivin. Cell Cycle (Georgetown, Tex.). 12: 522-32. PMID 23324341 DOI: 10.4161/Cc.23407  0.557
2013 Tecleab A, Zhang X, Sebti SM. Abstract 767: RalGTPase regulation of p53 and its contribution to malignant transformation. Cancer Research. 73: 767-767. DOI: 10.1158/1538-7445.Am2013-767  0.432
2011 Tecleab A, Sebti SM. Abstract 3844: K-Ras is required for maintaining survivin protein stability in human cancer cells harboring mutant but not wild type K-Ras Cancer Research. 71: 3844-3844. DOI: 10.1158/1538-7445.Am2011-3844  0.543
Show low-probability matches.